Cardinal Health Recalls Rugby Benzoyl Peroxide Gel Due to Temperature Excursions
Cardinal Health Inc. is recalling 189 tubes of Rugby Benzoyl Peroxide Gel 5% due to intermittent temperature excursions during storage.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text cites CGMP deviations regarding temperature excursions without reporting any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Cardinal Health Inc. is recalling 189 tubes of Rugby Benzoyl Peroxide (Benzoyl Peroxide) Gel USP, 5%, Net Wt 1.5 oz (42.5 g). The product is an over-the-counter acne medication distributed by Rugby Laboratories.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations involving intermittent exposure to temperature excursions during storage. The affected lots were distributed between February 23, 2021, and March 10, 2021.
The product was distributed in Florida, Georgia, and South Carolina. Consumers should check their supply of this product and stop using it if it matches the recalled description.
The recalled product
- Product
- RUGBY BENZOYL PEROXIDE (BENZOYL PEROXIDE)
- Brand
- RUGBY BENZOYL PEROXIDE
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Topical OTC
- Hazard
- Affected units
- 189
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots distributed 02/23/2021 through 03/10/2021.
Distribution
Part of a larger recall action
This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 198 products in this recall →Related recalls
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30